Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1X79
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,886
Award facts
- Contract value 100% obligated
- $29,885.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,885.67 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Dupixent 300 mg/2 mL pens in 2 mL quantities. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor registered in the System for Award Management.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The Dupixent delivery supports the Defense Health Agency and other federal healthcare systems in their distribution of this specialty medication used primarily for treating atopic dermatitis, eosinophilic esophagitis, and asthma. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen demonstrates capability to meet federal medical procurement requirements through its extensive portfolio of brand-name and generic medications delivered across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1X79?
SPE2DR26F1X79 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F1X79 worth?
The government has obligated $29,886 on SPE2DR26F1X79.
Is contract SPE2DR26F1X79 an order under another contract?
Yes. SPE2DR26F1X79 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1X79 competed?
The extent of competition for SPE2DR26F1X79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award